The Impact of Litigation-Associated Reports on Signal Identification in the US FDA’s Adverse Event Reporting System.

HOME
>
論文・技術情報
>
The Impact of Litigation-Associated Reports on Signal Identification in the US FDA’s Adverse Event Reporting System.

アブストラクト
ジャーナル名	Drug safety
Pubmed追加日	2019/5/18
投稿者	Munoz, Monica A; Dal Pan, Gerald J
組織名	Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research,;US Food and Drug Administration, Silver Spring, MD, USA.;monica.munoz@fda.hhs.gov.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/31098918/